SCHEMBL23913405

SCHEMBL23913405

c1ccc(-c2cccc3c2oc2cc(-c4nc(-c5cccc(-c6cccc7c6sc6ccccc67)c5)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 10/20 0.46
ALOX5 P09917 3/20 0.45
GGPS1 O95749 1/20 0.37
PIK3CD O00329 2/20 0.37
PIK3CB P42338 2/20 0.37
BRD4 O60885 1/20 0.36
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
KCNH2 Q12809 1/20 0.36
BRDT Q58F21 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.35
ESR2 Q92731 1/20 0.35
MAPT P10636 1/20 0.33
F9 P00740 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23913447 0.97 PRKDC (0.44) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL21261197 0.97 PRKDC (0.46) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL23349600 0.96 PRKDC (0.46) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL23349783 0.96 PRKDC (0.46) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL19196052 0.96 ALOX5 (0.46) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL25458401 0.95 PRKDC (0.46) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL23349601 0.95 PRKDC (0.46) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL23349882 0.94 ALOX5 (0.45) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL23349598 0.94 ALOX5 (0.45) PRKDCALOX5GGPS1PIK3CDPIK3CB
SCHEMBL23228235 0.94 PRKDC (0.45) PRKDCALOX5GGPS1PIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 PRKDC 4327/4885ALOX5 1095/4885GGPS1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.